Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 164

1.

High serum substance P levels and mortality after malignant middle cerebral artery infarction.

Lorente L, Martín MM, Pérez-Cejas A, González-Rivero AF, Argueso M, Ramos L, Solé-Violán J, Cáceres JJ, Jiménez A, García-Marín V.

J Crit Care. 2020 Jan 20;57:1-4. doi: 10.1016/j.jcrc.2020.01.022. [Epub ahead of print]

PMID:
31991332
2.

Survey of adherence to treatment in inflammatory bowel disease. ENADEII study.

Alonso-Abreu I, Alarcón-Fernández O, Carrillo-Palau M, Ramos-López L, Gisbert JP, Chaparro M, Nos P, Jiménez A, Quintero-Carrión E; en representación de GETECCU.

Gastroenterol Hepatol. 2020 Jan 14. pii: S0210-5705(19)30263-8. doi: 10.1016/j.gastrohep.2019.10.007. [Epub ahead of print] English, Spanish.

PMID:
31948830
3.

Maintained high sustained serum malondialdehyde levels after severe brain trauma injury in non-survivor patients.

Lorente L, Martín MM, Abreu-González P, Ramos L, Cáceres JJ, Argueso M, Solé-Violán J, Jiménez A, García-Marín V.

BMC Res Notes. 2019 Dec 3;12(1):789. doi: 10.1186/s13104-019-4828-5.

4.

Higher Serum Melatonin Levels during the First Week of Malignant Middle Cerebral Artery Infarction in Non-Surviving Patients.

Lorente L, Martín MM, Abreu-González P, Sabatel R, Ramos L, Argueso M, Solé-Violán J, Cáceres JJ, Jiménez A, García-Marín V.

Brain Sci. 2019 Nov 28;9(12). pii: E346. doi: 10.3390/brainsci9120346.

5.

Hepatitis C virus media coverage favorably impacts on antibody testing in the non-interferon era.

Morales-Arraez D, Hernandez-Guerra M, Diaz-Flores F, Nieto-Bujalance Y, Garcia-Dopico J, Jimenez A, Quintero E.

J Public Health (Oxf). 2019 Nov 30. pii: fdz149. doi: 10.1093/pubmed/fdz149. [Epub ahead of print]

PMID:
31786606
6.

High Serum Tissue Inhibitor of Matrix Metalloproteinase-1 Levels and Mortality in Patients with Spontaneous Intracerebral Hemorrhage.

Lorente L, Martín MM, Ramos L, Argueso M, Cáceres JJ, Solé-Violán J, Jiménez A.

World Neurosurg. 2020 Feb;134:e476-e480. doi: 10.1016/j.wneu.2019.10.106. Epub 2019 Oct 25.

PMID:
31669537
7.

High Serum Caspase-Cleaved Cytokeratin-18 Levels and Mortality of Traumatic Brain Injury Patients.

Lorente L, Martín MM, González-Rivero AF, Pérez-Cejas A, Argueso M, Ramos L, Solé-Violán J, Cáceres JJ, Jiménez A, García-Marín V.

Brain Sci. 2019 Oct 10;9(10). pii: E269. doi: 10.3390/brainsci9100269.

8.

Non-survivor patients with malignant middle cerebral artery infarction showed persistently high serum malondialdehyde levels.

Lorente L, Martín MM, Abreu-González P, Sabatel R, Ramos L, Argueso M, Solé-Violán J, Cáceres JJ, Jiménez A, García-Marín V.

BMC Neurol. 2019 Oct 17;19(1):238. doi: 10.1186/s12883-019-1479-z.

9.

High Serum DNA and RNA Oxidative Damage in Non-surviving Patients with Spontaneous Intracerebral Hemorrhage.

Lorente L, Martín MM, González-Rivero AF, Pérez-Cejas A, Abreu-González P, Sabatel R, Ramos L, Argueso M, Cáceres JJ, Solé-Violán J, Jiménez A, García-Marín V.

Neurocrit Care. 2019 Oct 9. doi: 10.1007/s12028-019-00864-8. [Epub ahead of print]

PMID:
31598840
10.

The Serum Melatonin Levels and Mortality of Patients with Spontaneous Intracerebral Hemorrhage.

Lorente L, Martín MM, Abreu-González P, Ramos L, Argueso M, Solé-Violán J, Cáceres JJ, Jiménez A, García-Marín V.

Brain Sci. 2019 Oct 1;9(10). pii: E263. doi: 10.3390/brainsci9100263.

11.

Reply to 'Strengths and limitations of estimated and measured GFR'.

Porrini E, Ruggenenti P, Luis-Lima S, Carrara F, Jiménez A, de Vries APJ, Torres A, Gaspari F, Remuzzi G.

Nat Rev Nephrol. 2019 Dec;15(12):785-786. doi: 10.1038/s41581-019-0214-8. No abstract available.

PMID:
31578496
12.

Risk of liver fibrosis progression in patients with suboptimal diagnosis of hepatitis C virus infection.

Morales-Arraez D, Nieto Bujalance Y, Diaz-Flores F, de Vera A, Jiménez A, Garcia Dopico JA, Quintero E, Hernández-Guerra M.

Eur J Gastroenterol Hepatol. 2019 Sep 3. doi: 10.1097/MEG.0000000000001534. [Epub ahead of print]

PMID:
31490420
13.

Patients with suboptimal hepatitis B virus diagnostic characterization are at risk of liver fibrosis progression.

Morales-Arraez D, Diaz-Flores F, Alonso A, de Vera A, Jimenez A, Garcia Dopico JA, Quintero E, Hernández-Guerra M.

Eur J Gastroenterol Hepatol. 2020 Mar;32(3):426-432. doi: 10.1097/MEG.0000000000001527.

PMID:
31490418
14.

High Serum sCD40L Levels During the First Week of Malignant Middle Cerebral Artery Infarction and Mortality.

Lorente L, Martín MM, González-Rivero AF, Sabatel R, Ramos L, Argueso M, Cáceres JJ, Solé-Violán J, Alvarez-Castillo A, Jiménez A, Borreguero-León JM, García-Marín V.

World Neurosurg. 2019 Dec;132:e630-e636. doi: 10.1016/j.wneu.2019.08.060. Epub 2019 Aug 21.

PMID:
31442656
15.

Persistently High Serum Substance P Levels and Early Mortality in Patients with Severe Traumatic Brain Injury.

Lorente L, Martín MM, Pérez-Cejas A, González-Rivero AF, Argueso M, Ramos L, Solé-Violán J, Cáceres JJ, Jiménez A, García-Marín V.

World Neurosurg. 2019 Dec;132:e613-e617. doi: 10.1016/j.wneu.2019.08.064. Epub 2019 Aug 20.

PMID:
31442647
16.

Association between DNA and RNA oxidative damage and mortality in septic patients.

Lorente L, Martín MM, González-Rivero AF, Pérez-Cejas A, Abreu-González P, Ortiz-López R, Ferreres J, Solé-Violán J, Labarta L, Díaz C, Palmero S, Jiménez A.

J Crit Care. 2019 Dec;54:94-98. doi: 10.1016/j.jcrc.2019.08.008. Epub 2019 Aug 5.

PMID:
31401543
17.

Association Between DNA and RNA Oxidative Damage and Mortality of Patients with Traumatic Brain Injury.

Lorente L, Martín MM, González-Rivero AF, Pérez-Cejas A, Abreu-González P, Ramos L, Argueso M, Cáceres JJ, Solé-Violán J, Alvarez-Castillo A, Jiménez A, García-Marín V.

Neurocrit Care. 2019 Aug 5. doi: 10.1007/s12028-019-00800-w. [Epub ahead of print]

PMID:
31385181
18.

High serum levels of tissue inhibitor of matrix metalloproteinase-1 during the first week of a malignant middle cerebral artery infarction in non-surviving patients.

Lorente L, Martín MM, Ramos L, Argueso M, Cáceres JJ, Solé-Violán J, Jiménez A, Borreguero-León JM, González-Rivero AF, Orbe J, Rodríguez JA, Páramo JA.

BMC Neurol. 2019 Jul 18;19(1):167. doi: 10.1186/s12883-019-1401-8.

19.

Serum Caspase-3 Levels and Early Mortality of Patients with Malignant Middle Cerebral Artery Infarction.

Lorente L, Martín MM, Pérez-Cejas A, González-Rivero AF, Sabatel R, Ramos L, Argueso M, Solé-Violán J, Cáceres JJ, Jiménez A, García-Marín V.

Neurocrit Care. 2019 Dec;31(3):486-493. doi: 10.1007/s12028-019-00739-y.

PMID:
31115825
20.

High serum caspase-3 levels in hepatocellular carcinoma prior to liver transplantation and high mortality risk during the first year after liver transplantation.

Lorente L, Rodriguez ST, Sanz P, González-Rivero AF, Pérez-Cejas A, Padilla J, Díaz D, González A, Martín MM, Jiménez A, Cerro P, Portero J, Barrera MA.

Expert Rev Mol Diagn. 2019 Jul;19(7):635-640. doi: 10.1080/14737159.2019.1619549. Epub 2019 May 20.

PMID:
31084510

Supplemental Content

Loading ...
Support Center